Urinary extracellular vesicles contain mature transcriptome enriched in circular and long noncoding RNAs with functional significance in prostate cancer

Abstract Long noncoding (lnc)RNAs modulate gene expression alongside presenting unexpected source of neoantigens. Despite their immense interest, their ability to be transferred and control adjacent cells is unknown. Extracellular Vesicles (EVs) offer a protective environment for nucleic acids, with pro and antitumourigenic functions by controlling the immune response. In contrast to extracellular nonvesicular RNA, few studies have addressed the full RNA content within human fluids’ EVs and have compared them with their tissue of origin. Here, we performed Total RNA‐Sequencing on six Formalin‐Fixed‐Paraffin‐Embedded (FFPE) prostate cancer (PCa) tumour tissues and their paired urinary (u)EVs to provide the first whole transcriptome comparison from the same patients. UEVs contain simplified transcriptome with intron‐free cytoplasmic transcripts and enriched lnc/circular (circ)RNAs, strikingly common to an independent 20 patients’ urinary cohort. Our full cellular and EVs transcriptome comparison within three PCa cell lines identified a set of overlapping 14 uEV‐circRNAs characterized as essential for prostate cell proliferation in vitro and 28 uEV‐lncRNAs belonging to the cancer‐related lncRNA census (CLC2). In addition, we found 15 uEV‐lncRNAs, predicted to encode 768 high‐affinity neoantigens, and for which three of the encoded‐ORF produced detectable unmodified peptides by mass spectrometry. Our dual analysis of EVs‐lnc/circRNAs both in urines’ and in vitro’s EVs provides a fundamental resource for future uEV‐lnc/circRNAs phenotypic characterization involved in PCa.

[1]  T. M. Zanotto,et al.  MicroRNA sequence codes for small extracellular vesicle release and cellular retention , 2021, Nature.

[2]  Ming-zhu Yin,et al.  KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements , 2021, Nature.

[3]  M. Taheri,et al.  A review on the role of PCAT6 lncRNA in tumorigenesis. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  A. Morillon,et al.  From Yeast to Mammals, the Nonsense-Mediated mRNA Decay as a Master Regulator of Long Non-Coding RNAs Functional Trajectory , 2021, Non-coding RNA.

[5]  V. Pascual,et al.  Extracellular vesicle– and particle-mediated communication shapes innate and adaptive immune responses , 2021, The Journal of experimental medicine.

[6]  G. Schroth,et al.  The RNA Atlas expands the catalog of human non-coding RNAs , 2021, Nature Biotechnology.

[7]  Jacob D. Jaffe,et al.  Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity , 2021, Nature.

[8]  A. Hill,et al.  Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles , 2021, Journal of extracellular vesicles.

[9]  T. H. van der Kwast,et al.  Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression , 2021, Nature Cell Biology.

[10]  Gene W. Yeo,et al.  Transcriptome-wide profiles of circular RNA and RNA-binding protein interactions reveal effects on circular RNA biogenesis and cancer pathway expression , 2020, Genome medicine.

[11]  L. Groop,et al.  Comparison of urinary extracellular vesicle isolation methods for transcriptomic biomarker research in diabetic kidney disease , 2020, Journal of extracellular vesicles.

[12]  Rienk Nieuwland,et al.  Methods for Separation and Characterization of Extracellular Vesicles: Results of a Worldwide Survey Performed by the ISEV Rigor and Standardization Subcommittee , 2020, Cells.

[13]  Xuesen Dong,et al.  Circular RNA and its potential as prostate cancer biomarkers , 2020, World journal of clinical oncology.

[14]  Amber L. Simpson,et al.  Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers , 2020, Cell.

[15]  Ling-Ling Chen The expanding regulatory mechanisms and cellular functions of circular RNAs , 2020, Nature Reviews Molecular Cell Biology.

[16]  Rory Johnson,et al.  Cancer LncRNA Census 2 (CLC2): an enhanced resource reveals clinical features of cancer lncRNAs , 2020, bioRxiv.

[17]  R. Kalluri,et al.  Exosomes as a Multicomponent Biomarker Platform in Cancer. , 2020, Trends in cancer.

[18]  M. Mann,et al.  Pervasive functional translation of noncanonical human open reading frames , 2020, Science.

[19]  Raghu Kalluri,et al.  The biology, function, and biomedical applications of exosomes , 2020, Science.

[20]  P. Ivanov,et al.  Fragmentation of extracellular ribosomes and tRNAs shapes the extracellular RNAome , 2020, bioRxiv.

[21]  P. Deininger,et al.  Comparative analysis on the expression of L1 loci using various RNA-Seq preparations , 2020, Mobile DNA.

[22]  F. Zhao,et al.  Accurate quantification of circular RNAs identifies extensive circular isoform switching events , 2020, Nature Communications.

[23]  D. Gautheret,et al.  Reference-free transcriptome exploration reveals novel RNAs for prostate cancer diagnosis , 2019, Life Science Alliance.

[24]  G. Schroth,et al.  Charting extracellular transcriptomes in The Human Biofluid RNA Atlas , 2019, bioRxiv.

[25]  V. Marchand,et al.  Diversity and heterogeneity of extracellular RNA in human plasma. , 2019, Biochimie.

[26]  Jørgen Kjems,et al.  The biogenesis, biology and characterization of circular RNAs , 2019, Nature Reviews Genetics.

[27]  J. Vandesompele,et al.  Performance assessment of total RNA sequencing of human biofluids and extracellular vesicles , 2019, Scientific Reports.

[28]  Jiong Wu,et al.  Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis. , 2019, Clinical chemistry.

[29]  J. Lötvall,et al.  Advances in therapeutic applications of extracellular vesicles , 2019, Science Translational Medicine.

[30]  Ryan M Spengler,et al.  Phospho‐RNA‐seq: a modified small RNA‐seq method that reveals circulating mRNA and lncRNA fragments as potential biomarkers in human plasma , 2019, The EMBO journal.

[31]  R. Schekman,et al.  Distinct mechanisms of microRNA sorting into cancer cell-derived extracellular vesicle subtypes , 2019, bioRxiv.

[32]  Eliot T. McKinley,et al.  Transfer of Functional Cargo in Exomeres , 2019, Cell reports.

[33]  Dylan T Burnette,et al.  Reassessment of Exosome Composition , 2019, Cell.

[34]  Alexander R. Pico,et al.  exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids , 2019, Cell.

[35]  Leng Han,et al.  Circular RNAs as promising biomarkers in cancer: detection, function, and beyond , 2019, Genome Medicine.

[36]  Sang Kook Lee,et al.  Circular RNAs in Cancer , 2019, Molecular therapy. Nucleic acids.

[37]  S. Dhanasekaran,et al.  The Landscape of Circular RNA in Cancer , 2019, Cell.

[38]  Alain Bergeron,et al.  Widespread and Functional RNA Circularization in Localized Prostate Cancer , 2019, Cell.

[39]  Clotilde Théry,et al.  Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication , 2019, Nature Cell Biology.

[40]  Martin Eisenacher,et al.  The PRIDE database and related tools and resources in 2019: improving support for quantification data , 2018, Nucleic Acids Res..

[41]  P. Gendron,et al.  Noncoding regions are the main source of targetable tumor-specific antigens , 2018, Science Translational Medicine.

[42]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[43]  M. Bonin,et al.  Evaluation of serum extracellular vesicle isolation methods for profiling miRNAs by next-generation sequencing , 2018, Journal of extracellular vesicles.

[44]  Graça Raposo,et al.  Shedding light on the cell biology of extracellular vesicles , 2018, Nature Reviews Molecular Cell Biology.

[45]  Hai Wu,et al.  Androgen-responsive circular RNA circSMARCA5 is up-regulated and promotes cell proliferation in prostate cancer. , 2017, Biochemical and biophysical research communications.

[46]  M. Nielsen,et al.  NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data , 2017, The Journal of Immunology.

[47]  G. Calin,et al.  A total transcriptome profiling method for plasma-derived extracellular vesicles: applications for liquid biopsies , 2017, Scientific Reports.

[48]  Bernd Giebel,et al.  Concise Review: Developing Best‐Practice Models for the Therapeutic Use of Extracellular Vesicles , 2017, Stem cells translational medicine.

[49]  P. Bradley,et al.  Quantifiable predictive features define epitope-specific T cell receptor repertoires , 2017, Nature.

[50]  Patrizia Agostinis,et al.  EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research , 2017, Nature Methods.

[51]  S. Heath,et al.  A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue Samples , 2017, PloS one.

[52]  Joshua M. Weiss,et al.  Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. , 2016, Cancer cell.

[53]  William Stafford Noble,et al.  Fast and Accurate Protein False Discovery Rates on Large-Scale Proteomics Data Sets with Percolator 3.0 , 2016, Journal of The American Society for Mass Spectrometry.

[54]  Clotilde Théry,et al.  Communication by Extracellular Vesicles: Where We Are and Where We Need to Go , 2016, Cell.

[55]  Minghui Wang,et al.  Efficient Test and Visualization of Multi-Set Intersections , 2015, Scientific Reports.

[56]  Ralph Weissleder,et al.  Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters , 2015, Nature Communications.

[57]  D. Bartel,et al.  Principles of long noncoding RNA evolution derived from direct comparison of transcriptomes in 17 species. , 2015, Cell reports.

[58]  R. Zeillinger,et al.  Correlation of circular RNA abundance with proliferation – exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues , 2015, Scientific Reports.

[59]  S. Dhanasekaran,et al.  The landscape of long noncoding RNAs in the human transcriptome , 2015, Nature Genetics.

[60]  A. Sivachenko,et al.  Massively Parallel Sequencing of Human Urinary Exosome/Microvesicle RNA Reveals a Predominance of Non-Coding RNA , 2014, PloS one.

[61]  J. Nielsen,et al.  Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics. , 2014, Molecular & cellular proteomics : MCP.

[62]  F. Sánchez‐Madrid,et al.  Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.

[63]  J. Kjems,et al.  Natural RNA circles function as efficient microRNA sponges , 2013, Nature.

[64]  Michael K. Slevin,et al.  Circular RNAs are abundant, conserved, and associated with ALU repeats. , 2013, RNA.

[65]  Howard Y. Chang,et al.  Genome regulation by long noncoding RNAs. , 2012, Annual review of biochemistry.

[66]  Nicholas T. Ingolia,et al.  The translational landscape of mTOR signalling steers cancer initiation and metastasis , 2012, Nature.

[67]  J. Rinn,et al.  Large non-coding RNAs: missing links in cancer? , 2010, Human molecular genetics.

[68]  X. Breakefield,et al.  Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer , 2009, British Journal of Cancer.

[69]  Johan Skog,et al.  Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.

[70]  Emmanuel Barillot,et al.  myProMS, a web server for management and validation of mass spectrometry‐based proteomic data , 2007, Proteomics.

[71]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[72]  Aled Clayton,et al.  Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.

[73]  L. Zitvogel,et al.  Exosomes as Potent Cell-Free Peptide-Based Vaccine. II. Exosomes in CpG Adjuvants Efficiently Prime Naive Tc1 Lymphocytes Leading to Tumor Rejection 1 , 2004, The Journal of Immunology.

[74]  Laurence Zitvogel,et al.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming , 2001, Nature Medicine.